Daily
-
Helping Doctors Help Patients: Digital Health’s Role in Reinventing How the Work That is Healthcare is Delivered
Investing in Friction-reducing tactics such as community building and providing benefits, training, and personalized support to employees will yield compounding long-term benefits while reducing churn rate.
-
Report: Annual Family Premiums for Employer Coverage Increase 7%
Annual family premiums for employer-sponsored coverage reached $23,968 in 2023, according to a new KFF survey. Of that family premium total, workers are contributing $6,575 annually.
-
The Vibe at Vive 2023: First Dollar
Jason Bornhorst, First Dollar CEO and co-founder, explained why the current healthcare benefits infrastructure isn’t doing enough to serve patients and health plans.
-
In Same Day, UCB Lands Two FDA Drug Approvals in Autoimmune Diseases
FDA approval of UCB’s Bimzelx gives the Belgian drugmaker a contender in the crowded plaque psoriasis therapies market. In the rare disease generalized myasthenia gravis, the agency approved Zilbrysq, a UCB drug with advantages over two blockbuster AstraZeneca drugs addressing the same target.
-
Allara Snags $10M to Scale Its Platform for Women’s Chronic Hormonal Conditions
Allara raised $10 million in a Series A funding round led by GV. The startup offers membership-based virtual services to treat women’s chronic hormonal conditions, such as PCOS and endometriosis. CEO Rachel Blank — former executive at Ro and investor at General Catalyst — founded the company partly due to the difficulty she experienced arriving at her own PCOS diagnosis.
-
Consumer / Employer, Health Tech
Amazon Starts Delivering Medications via Drone
Amazon Pharmacy is now offering a drone delivery service for prescription medications in College Station, Texas. The service is free and allows patients to receive their medications within 60 minutes.
-
Heard at HLTH: Healthcare Execs Share Perspectives on AI, Virtual Health and Value-based Care
As part of the Heard at HLTH video series, MedCity News Editor in Chief Arundhati Parmar and Senior Reporter Katie Adams interviewed healthcare executives about innovations in health tech at HLTH 2023 in Las Vegas earlier this month.
-
How Mass General Brigham Is Integrating Behavioral Care Into Its Primary Care Model
Mass General Brigham launched a program this month in collaboration with behavioral health medical group Concert Health. Under the program, more than 400 Mass General primary care providers can refer their patients to Concert. The health system’s goal is to increase patients’ access to diagnoses and treatment for mild to moderate behavioral health issues — particularly for Medicaid patients, who are the most underserved.
-
Obesity Care Startup Launches With $3M in Funding
Ilant Health launched out of stealth Tuesday. The company serves employers and payers and helps identify patients in need of obesity treatment and matches them to the care best for them.
-
Can Psychedelic-Assisted Therapy Be Used for Prevention?
Psychedelic-assisted therapy is currently used to treat severe mental health conditions. But there is evidence it could help with prevention as well, and more research needs to be done on this, said Sherry Rais, CEO and co-founder of Enthea.
-
Convergence of medtech and health tech: Helping providers plan procedures and easing patient anxiety
A pediatric health system enlisting mixed reality and 3D printing technology illustrates how clinical collaboration and patient education can improve patient outcomes for complex procedures.
-
Cedars-Sinai’s CMIO Has A Piece of Advice for AI Startups
At HLTH, Shaun Miller — Cedars-Sinai’s chief medical information officer — pointed out one thing he thinks healthcare AI companies haven’t quite gotten right yet. He said he would “really like there to be a lot more recognition around the personalization of AI and the ability for technology to understand that not every clinician is the same.”
-
Roche Deal Aims to Get Molecular Glues to Stick to Elusive Cancer, Neuro Targets
Roche is paying $50 million up front to begin a drug R&D alliance with Monte Rosa Therapeutics, a biotech whose molecular glue technology could address targets previously deemed undruggable. It’s Roche’s second such deal in the past month.
-
Microsoft’s Healthcare AI Efforts Holds Huge Promise for Patients
In a preview before the official announcement at HLTH last week, Microsoft executives and its hospital customers shared use cases of how its suite of AI tools can be used by health systems to improve healthcare delivery and alleviate provider burnout.
-
How Mayo Clinic Is Approaching Generative AI Risk Mitigation
At HLTH, Mayo Clinic Platform President John Halamka gave a window into how his health system is mitigating generative AI risks. Some of the measures Mayo is taking include running analyses on how well algorithms perform across various subgroups and training models only on internal de-identified data.
-
Pfizer Shaves Revenue Projections, Starts Cost-Cutting Plan Amid Lower Covid-19 Product Demand
Pfizer lowered its revenue projections for 2023, a change it attributed to declining demand for its Covid-19 vaccine, Comirnaty, and antiviral drug, Paxlovid. Citing this revenue decline, Pfizer is implementing a companywide cost-cutting plan projected to save $3.5 billion.